Eaton Vance Management Twist Bioscience Corp Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
Shares
2 transactions
Others Institutions Holding TWST
# of Institutions
256Shares Held
66.8MCall Options Held
127KPut Options Held
45.4K-
Artisan Partners Limited Partnership Milwaukee, WI6.02MShares$254 Million0.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$237 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$229 Million0.01% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.36MShares$226 Million2.3% of portfolio
-
Invesco Ltd. Atlanta, GA3.64MShares$154 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.38B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...